Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve Endometriosis care.

We are committed to improving the diagnosis, treatment, and ongoing care for gynaecological conditions including endometriosis, and we are taking action to address this, including delivering 5.2 million extra appointments between July 2024 and June 2025 across all specialities including gynaecology.

In September 2025, we announced an “online hospital”, via NHS Online, which will give people the choice of getting the specialist care they need from their home. NHS Online will help to reduce patient waiting times, delivering the equivalent of up to 8.5 million appointments and assessments in its first three years, four times more than an average trust, while enhancing patient choice and control over their care. Menstrual problems which may be a sign of endometriosis will be among the first conditions available for referral to NHS Online from 2027.

In November 2024, the National Institute for Health and Care Excellence (NICE) updated its guideline on endometriosis. This makes firmer recommendations for healthcare professionals on referral and investigations for women with suspected diagnosis and will help the estimated one in 10 women with endometriosis receive a diagnosis faster.

Additionally, research has led to new treatments being made available, including the NICE approval of two pills to treat endometriosis this year, Relugolix and Linzagolix. Both are estimated to help approximately 1,000 women with severe endometriosis for whom other treatment options haven’t been effective. NICE is working with National Health Service systems to ensure adoption of this best practice of endometriosis care, including access to approved medicines.

NHS England is updating the service specification for severe endometriosis which will be published in due course. This will improve the standards of care for women with severe endometriosis by ensuring specialist services have access to the most up-to-date evidence and advice.

The Department, through the National Institute for Health and Care Research (NIHR), has commissioned a number of studies focused on endometriosis diagnosis, treatment and patient experience. At present, the NIHR is funding seven active research awards totalling an investment of approximately £7.8 million. This includes a new £2.3 million award on the effectiveness of pain management for endometriosis starting in March 2026.